Literature DB >> 2277270

Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit.

G Arendt1, H Hefter, C Elsing, G Strohmeyer, H J Freund.   

Abstract

Motor tests were performed in 50 HIV-infected patients in all stages according to the current CDC classification, but without any clinically evident central nervous system deficit, and the results compared with an age-matched control group. Patients were excluded from the study if there was alcohol or drug abuse, fever and/or opportunistic cerebral infection. The parameters tested were postural tremor of the outstretched hands, most rapid voluntary alternating index finger movements (MRAM) and rise time of most rapid index finger extensions (MRC). Whereas tremor peak frequencies did not differ significantly in the patients and controls, MRAM and rise times of MRCs showed significant slowing in the patient group. Morphologically, the motor test performance of the HIV-infected patients was similar to that of patients with manifest basal ganglia disease (Parkinson's, Huntington's and Wilson's diseases). MRI scans of all patients were normal. It is concluded that in HIV-infected patients there is a very early subclinical central nervous system affection, especially of the basal ganglia, which is detectable with appropriate, quantitative motor function tests. These functional abnormalities precede the structural alterations in the MRI scans.

Entities:  

Mesh:

Year:  1990        PMID: 2277270     DOI: 10.1007/bf00315660

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  35 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

3.  Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS.

Authors:  D H Gabuzda; D D Ho; S M de la Monte; M S Hirsch; T R Rota; R A Sobel
Journal:  Ann Neurol       Date:  1986-09       Impact factor: 10.422

4.  Reaction time in Parkinson's disease.

Authors:  E V Evarts; H Teräväinen; D B Calne
Journal:  Brain       Date:  1981-03       Impact factor: 13.501

5.  Hypothesis: AIDS encephalopathy is due to primary and persistent infection of the brain with a human retrovirus of the lentivirus subfamily.

Authors:  L G Epstein; L R Sharer; D C Gajdusek
Journal:  Med Hypotheses       Date:  1986-09       Impact factor: 1.538

6.  Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinucleated giant cells.

Authors:  T Kato; A Hirano; J F Llena; H M Dembitzer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  Central nervous system disease in acquired immunodeficiency syndrome: prospective correlation using CT, MR imaging, and pathologic studies.

Authors:  M J Post; J J Sheldon; G T Hensley; K Soila; J A Tobias; J C Chan; R M Quencer; L B Moskowitz
Journal:  Radiology       Date:  1986-01       Impact factor: 11.105

8.  Impairment of rapid movement in Huntington's disease.

Authors:  H Hefter; V Hömberg; H W Lange; H J Freund
Journal:  Brain       Date:  1987-06       Impact factor: 13.501

9.  Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS).

Authors:  H Budka
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  25 in total

1.  Reward, attention, and HIV-related risk in HIV+ individuals.

Authors:  Brian A Anderson; Sharif I Kronemer; Jessica J Rilee; Ned Sacktor; Cherie L Marvel
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

2.  Simplification of combination antiretroviral therapy (cART) and the brain-a real-life experience.

Authors:  Gabriele Arendt; Svenja Schlonies; Eser Orhan; Olaf Stüve
Journal:  J Neurovirol       Date:  2019-01-09       Impact factor: 2.643

3.  Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity.

Authors:  Mario Ortega; Matthew R Brier; Beau M Ances
Journal:  AIDS       Date:  2015-03-27       Impact factor: 4.177

Review 4.  Affective disorders in patients with HIV infection: impact of antiretroviral therapy.

Authors:  Gabriele Arendt
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Electrophysiological motor testing, MRI findings and clinical course in AIDS patients with dementia.

Authors:  G Arendt; H Hefter; E Neuen-Jacob; S Wist; H Kuhlmann; G Strohmeyer; H J Freund
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

Review 6.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444

Review 7.  Behavioral and neurophysiological hallmarks of simian immunodeficiency virus infection in macaque monkeys.

Authors:  P D Cheney; M Riazi; J M Marcario
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

8.  HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers.

Authors:  H J von Giesen; H Hefter; H Roick; S Mauss; G Arendt
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

9.  Dopamine deficits and regulation of the cAMP second messenger system in brains of simian immunodeficiency virus-infected rhesus monkeys.

Authors:  M Jenuwein; C Scheller; E Neuen-Jacob; S Sopper; T Tatschner; V ter Meulen; P Riederer; E Koutsilieri
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.